129 related articles for article (PubMed ID: 37978956)
1. The Association Between Hormonal Contraceptive Use and Anemia Among Adolescent Girls and Young Women: An Analysis of Data From 51 Low- and Middle-Income Countries.
Misunas C; Hindin MJ; Phillips-Howard PA; Sommer M
J Adolesc Health; 2024 Mar; 74(3):563-572. PubMed ID: 37978956
[TBL] [Abstract][Full Text] [Related]
2. The relationship between history of hormonal contraceptive use and iron status among women in Tanzania: A population-based study.
Haile ZT; Kingori C; Teweldeberhan AK; Chavan B
Sex Reprod Healthc; 2017 Oct; 13():97-102. PubMed ID: 28844365
[TBL] [Abstract][Full Text] [Related]
3. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
Milman N; Clausen J; Byg KE
Ann Hematol; 1998; 77(1-2):13-9. PubMed ID: 9760147
[TBL] [Abstract][Full Text] [Related]
4. Trends in contraceptive use according to HIV status among privately insured women in the United States.
Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
[TBL] [Abstract][Full Text] [Related]
5. Condom use by Hispanic and African-American adolescent girls who use hormonal contraception.
Roye CF
J Adolesc Health; 1998 Oct; 23(4):205-11. PubMed ID: 9763156
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral contraception on anemia in 12 low- and middle-income countries.
Bellizzi S; Ali MM
Contraception; 2018 Mar; 97(3):236-242. PubMed ID: 29133111
[TBL] [Abstract][Full Text] [Related]
7. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
8. Medical contraindications to estrogen and contraceptive use among women veterans.
Judge CP; Zhao X; Sileanu FE; Mor MK; Borrero S
Am J Obstet Gynecol; 2018 Feb; 218(2):234.e1-234.e9. PubMed ID: 29111146
[TBL] [Abstract][Full Text] [Related]
9. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cohen MA; Edelman A; Paynter R; Henderson JT
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
[TBL] [Abstract][Full Text] [Related]
10. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
Milman N; Rosdahl N; Lyhne N; Jørgensen T; Graudal N
Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
[TBL] [Abstract][Full Text] [Related]
11. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
Krashin J; Tang JH; Mody S; Lopez LM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
[TBL] [Abstract][Full Text] [Related]
12. Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.
Keyes KM; Cheslack-Postava K; Westhoff C; Heim CM; Haloossim M; Walsh K; Koenen K
Am J Epidemiol; 2013 Nov; 178(9):1378-88. PubMed ID: 24043440
[TBL] [Abstract][Full Text] [Related]
13. The hormonal ring. A new contraceptive gains acceptance.
Hardy EE; Reyes Q; Gomez F; Portes-carrasco R; Faundes A
IDRC Rep; 1984 Jul; 13(2):11. PubMed ID: 12313242
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraception and sexual desire: A questionnaire-based study of young Swedish women.
Malmborg A; Persson E; Brynhildsen J; Hammar M
Eur J Contracept Reprod Health Care; 2016; 21(2):158-67. PubMed ID: 26406399
[TBL] [Abstract][Full Text] [Related]
15. Multilevel analysis of anemia and associated factors among women of reproductive age (15-49 years) in Liberia: Evidence from the 2019/20 Liberia demographic and health survey data.
Adugna DG; Mengstie MA; Admasu FT; Teshome MG; Aragie H; Dejenie TA
PLoS One; 2024; 19(4):e0296747. PubMed ID: 38662746
[TBL] [Abstract][Full Text] [Related]
16. Association between experience of specific side-effects and contraceptive switching and discontinuation in Uganda: results from a longitudinal study.
Zimmerman LA; Sarnak DO; Karp C; Wood SN; Ahmed S; Makumbi F; Kibira SPS
Reprod Health; 2021 Nov; 18(1):239. PubMed ID: 34838097
[TBL] [Abstract][Full Text] [Related]
17. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
Paul R; Huysman BC; Maddipati R; Madden T
Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
[TBL] [Abstract][Full Text] [Related]
18. Determining Prevalence of Anemia and Its Associated Factors in Cameroon: A Multilevel Analysis.
Zegeye B; Ahinkorah BO; Ameyaw EK; Seidu AA; Keetile M; Yaya S
Biomed Res Int; 2021; 2021():9912549. PubMed ID: 34778462
[TBL] [Abstract][Full Text] [Related]
19. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.
Ponce de Leon RG; Ewerling F; Serruya SJ; Silveira MF; Sanhueza A; Moazzam A; Becerra-Posada F; Coll CVN; Hellwig F; Victora CG; Barros AJD
Lancet Glob Health; 2019 Feb; 7(2):e227-e235. PubMed ID: 30683240
[TBL] [Abstract][Full Text] [Related]
20. Sexual and reproductive health education and its association with ever use of contraception: a cross-sectional study among women in urban slums, Accra.
Seidu AA; Ameyaw EK; Ahinkorah BO; Baatiema L; Dery S; Ankomah A; Ganle JK
Reprod Health; 2022 Jan; 19(1):7. PubMed ID: 35033115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
